A report published in the November issue of the journal Osteoporosis International notes that Medicare reimbursement for dual-energy X-ray absorptiometry (DXA)—a key tool in the monitoring of osteoporosis—has been cut to levels substantially below the cost to perform the procedure, and as a result, healthcare providers may consider discontinuing the service. The authors cite a recent study that found that restoring DXA reimbursement to 2006 levels would save the Medicare program $1.14 billion over five years due to the reduced number of osteoporotic fractures.
Read More...
Comments